S. Blanchard et al., DIFFERENT HTLV-I NEUTRALIZATION PATTERNS AMONG SERA OF PATIENTS INFECTED WITH COSMOPOLITAN HTLV-I, Virology, 245(1), 1998, pp. 90-98
To determine if sequence variations observed in cosmopolitan HTLV-I in
terfered with viral recognition by neutralizing antibodies, we evaluat
ed the neutralization potential of sera from persons infected by HTLV-
I of this clade selected for amino acid changes in their env glycoprot
eins. Each serum was used to neutralize three previously described HTL
V-I isolates, 2060, 2072, and 1010, that possess amino acid env sequen
ces differing at several positions, one of them being located in the i
mmunodominant and neutralizable domain (aa 187-199). The results obtai
ned in syncytia and/or reporter gene inhibition assays showed that the
neutralization pattern of the sera clearly differed and could be clas
sified in three categories. Five sera completely neutralized the three
viruses with an equivalent titer, two sera gave a maximum inhibition,
with higher ID50 on the 2072 virus than on the 2060 or 1010 viruses,
and three sera had a stronger neutralization potential toward the 1010
virus than toward the 2060 virus. One of these sera partially neutral
ized the virus produced by 2072 cells, whereas neutralizing antibodies
in the other two recognized the neutralizable epitopes on the 1010 or
2072 viruses equally well. identification of amino acid sequences inv
olved in induction of neutralizing antibodies with different recogniti
on capacities could help identify new neutralizable epitopes of HTLV-I
envelope glycoproteins and to better define the component(s) of an ef
fective vaccine. (C) 1998 Academic Press.